The November deadline for including unique product identifiers on prescription drugs is putting a strain on multiple parts of the industry, much of which is …
When you walk into a store or pharmacy and see multiple similar products in the same competitive space, it is easy to understand the impact …
Many compounds are synthesised from raw materials in multi-batch and multi-ton quantities over extended time periods. The repetitious nature of the multi-batch business has proven …
The field of prefillable syringes is constantly turning up new trends and developments, driven by new active ingredients and a desire for patient safety at …
Outsourcing is on the rise, not only among big pharmaceutical firms but also with smaller emerging and even virtual companies, meaning customer requirements are more …
Environmental monitoring (EM) is an essential part of any pharmaceutical, medical device or biotechnology manufacturing process. It ensures that microbiological and particulate levels in the …
Fergus Hall, PhD, Section Manager, Pharmaceutical Chemistry at Eurofins BioPharma Product Testing, looks at the complexity of detecting and quantifying residual impurities which are usually …
Safety testing is a crucial part of drug development and is dictated by pharmacopoeial guidelines, which must be followed when performing each step of the …
As the nature of clinical trials grows ever more complex, the requirement for an improved risk-based monitoring (RBM) approach increases. Such an approach improves the …
By definition, medical research is about dealing with large quantities of data. That’s even truer in the leading edges of the life sciences, where tackling …
IPI was established by professionals with over 30 years of experience in the Pharmaceutical and Life sciences publishing sectors. Peer-Reviewed, Contemporary, Authoritative
